default author photo

Jens Köhler

Harvard University - Department of Medical Oncology

450 Brookline Avenue

Boston, MA 02115

United States

SCHOLARLY PAPERS

1

DOWNLOADS

100

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

An Integrative Pharmacogenomics Analysis Identifies Therapeutic Targets in KRAS-Mutant Lung Cancer

Number of pages: 42 Posted: 12 Jul 2019
Tongji University - School of Life Science and Technology, Tongji University - School of Life Science and Technology, Tongji University - Research Center for Translational Medicine, Tongji University - School of Life Science and Technology, Tongji University - School of Life Science and Technology, Tongji University - School of Life Science and Technology, Tongji University - School of Life Science and Technology, Harvard University - Lowe Center for Thoracic Oncology, Harvard University - Department of Medical Oncology and Harvard University - Department of Medical Oncology
Downloads 100 (689,572)

Abstract:

Loading...

Pharmacogenomic profiles, KRAS mutations, Lung adenocarcinoma, CSNK2A1